T1	Outcomes 726 797	safety profile, pharmacokinetics, immunogenicity, and clinical effects.
T2	Outcomes 833 847	adverse events
T3	Outcomes 924 966	drug-related hypotensive infusion reaction
T4	Outcomes 1152 1173	myocardial infarction
T5	Outcomes 1321 1330	half-life
T6	Outcomes 1421 1439	clinical activity.
